Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
British Journal of Clinical Pharmacology
|
July 29, 2015
Population pharmacokinetics of edoxaban in patients with symptomatic deep-vein thrombosis and/or pulmonary embolism--the Hokusai-VTE phase 3 study
Ronald Niebecker, Siv Jönsson, Mats O Karlsson, et al.
The Journal of Craniofacial Surgery
|
October 22, 2019
Langerhans Cell Histiocytosis in an Adult: A Discussion of Epidemiology and Treatment Options
Kaley K El-Arab, Alexis Inge Luedke, Bao-Quynh Thuy Julian, et al.
Journal of Agricultural and Food Chemistry
|
February 23, 2008
Cyanidin 3-rutinoside and cyanidin 3-xylosylrutinoside as primary phenolic antioxidants in black raspberry
Artemio Z Tulio, R Neil Reese, Faith J Wyzgoski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 3, 2010
Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database
Kaori Ito, Brian Corrigan, Qinying Zhao, et al.
Clinical Pharmacokinetics
|
March 9, 2016
Population Pharmacokinetics of Edoxaban in Patients with Non-Valvular Atrial Fibrillation in the ENGAGE AF-TIMI 48 Study, a Phase III Clinical Trial
Elke H J Krekels, Ronald Niebecker, Mats O Karlsson, et al.
Journal of Agricultural and Food Chemistry
|
March 3, 2010
Modeling relationships among active components in black raspberry (Rubus occidentalis L.) fruit extracts using high-resolution (1)H nuclear magnetic resonance (NMR) spectroscopy and multivariate statistical analysis
Faith J Wyzgoski, Liladhar Paudel, Peter L Rinaldi, et al.
Clinical Pharmacology in Drug Development
|
April 29, 2016
Model-Supported Development of CS-8635: A Fixed-Dose Combination of Olmesartan, Amlodipine, and Hydrochlorothiazide
SaeHeum Song, Timothy J Carrothers, Helen Moore, et al.
Circulation
|
July 4, 2018
Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial
Ophelia Q P Yin, Elliott M Antman, Eugene Braunwald, et al.
Journal of Agricultural and Food Chemistry
|
February 14, 2014
NMR-based metabolomic investigation of bioactivity of chemical constituents in black raspberry (Rubus occidentalis L.) fruit extracts
Liladhar Paudel, Faith J Wyzgoski, M Monica Giusti, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
November 12, 2005
How modeling and simulation have enhanced decision making in new drug development
Raymond Miller, Wayne Ewy, Brian W Corrigan, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
British Journal of Clinical Pharmacology
|
July 29, 2015
Population pharmacokinetics of edoxaban in patients with symptomatic deep-vein thrombosis and/or pulmonary embolism--the Hokusai-VTE phase 3 study
Ronald Niebecker, Siv Jönsson, Mats O Karlsson, et al.
The Journal of Craniofacial Surgery
|
October 22, 2019
Langerhans Cell Histiocytosis in an Adult: A Discussion of Epidemiology and Treatment Options
Kaley K El-Arab, Alexis Inge Luedke, Bao-Quynh Thuy Julian, et al.
Journal of Agricultural and Food Chemistry
|
February 23, 2008
Cyanidin 3-rutinoside and cyanidin 3-xylosylrutinoside as primary phenolic antioxidants in black raspberry
Artemio Z Tulio, R Neil Reese, Faith J Wyzgoski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 3, 2010
Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database
Kaori Ito, Brian Corrigan, Qinying Zhao, et al.
Clinical Pharmacokinetics
|
March 9, 2016
Population Pharmacokinetics of Edoxaban in Patients with Non-Valvular Atrial Fibrillation in the ENGAGE AF-TIMI 48 Study, a Phase III Clinical Trial
Elke H J Krekels, Ronald Niebecker, Mats O Karlsson, et al.
Journal of Agricultural and Food Chemistry
|
March 3, 2010
Modeling relationships among active components in black raspberry (Rubus occidentalis L.) fruit extracts using high-resolution (1)H nuclear magnetic resonance (NMR) spectroscopy and multivariate statistical analysis
Faith J Wyzgoski, Liladhar Paudel, Peter L Rinaldi, et al.
Clinical Pharmacology in Drug Development
|
April 29, 2016
Model-Supported Development of CS-8635: A Fixed-Dose Combination of Olmesartan, Amlodipine, and Hydrochlorothiazide
SaeHeum Song, Timothy J Carrothers, Helen Moore, et al.
Circulation
|
July 4, 2018
Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial
Ophelia Q P Yin, Elliott M Antman, Eugene Braunwald, et al.
Journal of Agricultural and Food Chemistry
|
February 14, 2014
NMR-based metabolomic investigation of bioactivity of chemical constituents in black raspberry (Rubus occidentalis L.) fruit extracts
Liladhar Paudel, Faith J Wyzgoski, M Monica Giusti, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
November 12, 2005
How modeling and simulation have enhanced decision making in new drug development
Raymond Miller, Wayne Ewy, Brian W Corrigan, et al.
Page
of 5